Global and United States Erythromycin Market Report & Forecast 2022-2028

Erythromycin is an antibiotic useful for the treatment of a number of bacterial infections. This includes respiratory tract infections, skin infections, chlamydia infections, pelvic inflammatory disease, and syphilis. It may also be used during pregnancy to prevent Group B streptococcal infection in the newborn, as well as to improve delayed stomach emptying. It can be given intravenously and by mouth. An eye ointment is routinely recommended after delivery to prevent eye infections in the newborn.
Market Analysis and Insights: Global and United States Erythromycin Market
This report focuses on global and United States Erythromycin market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Erythromycin market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Erythromycin Thiocyanate accounting for % of the Erythromycin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Human Medication was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Erythromycin market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Erythromycin Scope and Market Size
Erythromycin market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Erythromycin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Erythromycin market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Erythromycin Thiocyanate
Azithromycin
Clarithromycin
Roxithromycin
Others
Segment by Application
Human Medication
Veterinary Medication
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Kelun Chuanning Biotechnology
Ercros S.A.
HEC Group
Envee Drugs Pvt Ltd
Mehta Api
Abbvie
Ningxia Qiyuan
Calyx C & P
Alembic Pharma
SM Biomed
Anuh Pharma
Shaoxing Hantai Pharma